IFP Advisors, Inc - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,062
+16015.8%
200
-83.3%
0.00%
-100.0%
Q4 2022$19
-99.9%
1,2000.0%0.00%
Q3 2022$19,0000.0%1,2000.0%0.00%
-100.0%
Q2 2022$19,000
-13.6%
1,200
-14.3%
0.00%
Q1 2022$22,000
+1000.0%
1,400
+600.0%
0.00%
Q4 2021$2,000
-33.3%
2000.0%0.00%
Q3 2021$3,0000.0%2000.0%0.00%
Q2 2021$3,000
-25.0%
2000.0%0.00%
Q1 2021$4,000
+33.3%
200
-2.9%
0.00%
Q4 2020$3,000
-25.0%
206
-18.6%
0.00%
Q3 2020$4,0000.0%2530.0%0.00%
Q2 2020$4,0000.0%2530.0%0.00%
Q1 2020$4,0000.0%2530.0%0.00%
Q4 2019$4,000
-88.6%
253
-86.5%
0.00%
-100.0%
Q3 2019$35,000
+169.2%
1,880
+191.5%
0.00%0.0%
Q1 2019$13,000
-27.8%
645
-54.9%
0.00%
+100.0%
Q4 2018$18,000
-86.2%
1,430
-73.6%
0.00%
-80.0%
Q3 2018$130,000
+71.1%
5,421
+37.3%
0.01%
+66.7%
Q2 2018$76,000
+375.0%
3,948
+204.2%
0.00%
+200.0%
Q1 2018$16,0000.0%1,2980.0%0.00%0.0%
Q4 2017$16,000
+23.1%
1,298
+39.6%
0.00%0.0%
Q3 2017$13,000
+8.3%
930
+19.2%
0.00%0.0%
Q2 2017$12,000
-14.3%
780
+0.8%
0.00%0.0%
Q1 2017$14,000
+100.0%
774
-3.1%
0.00%
Q4 2016$7,000799
+699.0%
0.00%
Q2 2016$0
-100.0%
100
-84.5%
0.00%
-100.0%
Q1 2016$13,000
+85.7%
645
+61.2%
0.00%
Q4 2015$7,0004000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders